Role of APOE and Age at Enrollment in the Alzheimer’s Disease Anti-Inflammatory Prevention Trial (ADAPT)

Role of APOE and Age at Enrollment in the Alzheimer’s Disease Anti-Inflammatory Prevention Trial (ADAPT)

Background: The Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT) tested whether non-steroidal anti-inflammatory drugs (NSAIDs) can prevent Alzheimer’s disease (AD). The results were null. We analyzed ADAPT data to examine if the effects of NSAIDs on AD risk differed depending upon APOE...

Full description

Bibliographic Details
Main Authors: Lea T. Drye, Peter P. Zandi
Format: Article
Language:English
Published: Karger Publishers 2012-08-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Age
Prevention
Clinical trial
Alzheimer’s disease
Apolipoprotein E
Online Access:http://www.karger.com/Article/FullText/341783

Similar Items

Similar Items